Objective: The innate immune component TRIM5a has the ability to restrict retrovirus infection in a species-specific manner. TRIM5a of some primate species restricts infection by HIV-1, whereas human TRIM5a lacks this specificity. Previous studies have suggested that certain polymorphisms in human TRIM5a may enhance or impair the proteins affinity for HIV-1. This study investigates the role of TRIM5a polymorphisms in resistance/susceptibility to HIV-1 within the Pumwani sex worker cohort in Nairobi, Kenya. A group of women within this cohort remain HIV-1-seronegative and PCR-negative despite repeated exposure to HIV-1 through active sex work.
Introduction
According to the World Health Organization (WHO), there were 2.1 million deaths due to HIV and AIDS last pies can greatly extend the life expectancy of those living with HIV/AIDS, such treatments are expensive and remain largely inaccessible in developing countries. With the knowledge of natural immunity to HIV-1 constantly growing, it is becoming clear that intrinsic immune responses play an important role and may hold the key to an effective and accessible prophylactic [2] .
A recently discovered gene, TRIM5 (chromosome 11), has the ability to provide innate protection against retroviruses in the form of TRIM5a, a splice variant of TRIM5 [3] [4] [5] [6] [7] . Studies have shown that TRIM5a of old world monkeys, such as the Rhesus Macaque, is able to effectively inhibit HIV-1 infection [4, 5] . Whereas human TRIM5a does not completely inhibit HIV-1 infection, it has shown slight anti-HIVactivity and is known to restrict other retroviruses, such as the N-tropic murine-leukemia virus [3, 5, 6] . TRIM5a has highly variable regions and restricts retroviral infection in a species-specific manner [3] [4] [5] [6] [7] [8] . The B30.2 SPRY domain at the C-terminus of TRIM5a is the most variable region and has been shown to be responsible for capsid recognition and binding [9] [10] [11] [12] [13] . The coiled-coil is thought to be involved in TRIM5a multimerization and is essential for effective retroviral restriction [9, 10, [12] [13] [14] . It has been suggested that the RING and B-box domains are nonessential for capsid binding and viral restriction. The term 'effecter' has been applied to the RING and B-box regions as they enhance TRIM5a antiretroviral activity through possible interactions with other proteins [9, 12, 15] . The RING domain has been shown to affect cytoplasmic levels and distribution of TRIM5a [16] and act as an E3 ubiquitin ligase, targeting the virus for proteasomal degradation [12, 15] .
Previous studies have shown, with conflicting results, that certain polymorphisms may alter the potency of human TRIM5a against HIV-1 [3, [17] [18] [19] . Two single-nucleotide polymorphisms (SNPs) in particular have been at the center of many investigations: a G to A change in rs10838525 (R136Q in exon 2) and a C to T change in rs3740996 (H43Y in exon 2). A study by Javanbakht et al. [18] found the amino acid changes H43Y and R136Q associated with resistance to HIV-1 infection. Another study showed that 136Q associated with increased HIV-1 infection in a European population [3] . Neither of these studies found any association between TRIM5a SNPs and disease progression; however, Van Manen et al. [17] found 136Q correlated with slower disease progression and 43Y correlated with accelerated progression. These discrepancies suggest a need for further investigation into the effect human TRIM5a SNPs have on HIV-1 infection. This study set out to characterize genetic variations of TRIM5a within the Pumwani cohort at exon 2. Exon 2 contains the majority of previously identified nonsynonymous coding SNPs and makes up a large part of the functional protein ( Fig. 1) [3, 18] . This locus was also chosen due to the conflicting results obtained by previous studies concerning the effect of two specific SNPs on HIV-1 infection: H43Y and R136Q [3, 17] . Forover 20 years the HIV-1 infections of women enrolled in the Pumwani sex worker cohort in Nairobi, Kenya, have been closely monitored. Within the cohort, a group of womenremain HIV-1-seronegativedespite heavyexposure to HIV-1 through active sex work [20] . To study the role of TRIM5a polymorphisms in this observed natural resistance to HIV-1 infection, 1032 women of the Pumwani cohort were genotyped at exon 2. The SNP and haplotype frequencies in the cohort were investigated and correlations with HIV-1 resistance or susceptibility and disease progression were reported. Our findings suggest that TRIM5a polymorphisms play an important role in HIV-1 infection and the SNP causing the amino acid change to 136Q might play a key role in determining natural resistance to HIV-1 in the Pumwani sex worker cohort.
Methods

Study population
The study population consisted of 1032 women enrolled in the Pumwani sex worker cohort, established in 1985 in Nairobi, Kenya. Cohort design and follow-up have been discussed elsewhere [20] . The overall HIV-1 infection rate in the Pumwani sex worker cohort is greater than 73.7%. Women were classified as HIV-1-resistant if they remained HIV-seronegative and PCR-negative for at least 3 years while continuing active sex work and were negative at the time of this study. The 88 women who were classified as resistant in this study were all enrolled in the cohort before 1999 with an average follow-up time of 9.6 AE 4.3 years. The HIV-1-negative women who enrolled later and therefore had a shorter follow-up time were not included in the comparison between resistant women and positive women. HIV-1-negative women enrolled after 2001 were not included in the analysis for resistance or susceptibility to HIV-1 infection and all the HIV-1-infected women were included in the analysis for CD4þ T-cell decline to below 200 cells/ml. Informed consent was obtained from all women enrolled in the cohort. The ethics committees of the University of Manitoba and the University of Nairobi have approved this study.
TRIM5a genotyping DNA samples were isolated from whole blood and peripheral blood mononuclear cells (PBMCs) using QIAamp DNA Mini Kit (QIAGEN Inc., Mississauga, ON). A sequence-based genotyping method was used for TRIM5a exon 2 genotyping. TRIM5a exon 2 was amplified using a primer pair known to have successfully amplified exon 2 of human TRIM5a in previous studies [3] . PCR products were sequenced and analyzed for nucleotide variations using computer software Codo-nExpress. These nucleotide polymorphisms were recorded and grouped into haplotypes for analysis.
Statistical analysis
TRIM5a SNP and haplotype frequencies were determined using PyPop-32-0.6.0. Associations with HIV-1positive or resistant women in the cohort were analyzed using SPSS 13.0 for Windows (SPSS Inc., Chicago, Illinois, USA). Standard univariate methods such as the Fisher's exact test (P value) as well as Pearson chi-square analysis [odds ratio (OR) as well as Peto OR, 95% confidence interval (CI)] were utilized to determine the relationship between binary outcomes and explanatory variables. Kaplan-Meier analysis with log-rank test was used to examine the time to seroconversion for enrollees who were HIV-1-negative at enrolment. Only women enrolled in the cohort prior to 2001 were included in the survival analysis for HIV-1 infection. Since we have not retained blood samples for TRIM5a genotyping from all women enrolled during the first few years of the project, the probability of being TRIM5a-genotyped may depend on an individual's HIV status and duration of follow-up; therefore this selection mechanism had to be adjusted. According to the Hurvitz-Thompson theory, observations must be weighted inversely to the probability of being included in a sample to reach an unbiased estimate of what is being investigated [21] . We estimated the probability of being typed using logistic regression with follow-up and HIV status as covariables. The inverse of this probability for each woman, after standardization, was then used as a sample weight. We generated a weighted parameter using logistic regression taking into account patient enrolment and samples being typed. We used this parameter to adjust for cross-tab analyses and to compare the results with/without using this parameter. Associations were confirmed using binary logistic regression (backward Wald). SNPs or haplotypes found to be significant at the P < 0.05 level were tested for independent significance using binary logistic regression and Cox regression. Kaplan-Meier survival analysis (logrank test) was used to examine time to seroconversion and significant correlations were verified by Cox regression analysis. P values were adjusted for multiple comparisons by means of the Bonferroni method using an SPSS syntax created by David Nichols of SPSS.
Results
TRIM5a single-nucleotide polymorphisms identified in the Pumwani sex worker cohort Thirteen SNPs within the 1 kb genomic fragment containing exon 2 of TRIM5a were identified in the Pumwani sex worker cohort ( Table 1 ). Among them, nine SNPs are within exon 2 (seven nonsynonymous and two synonymous), three SNPs are in intron 2, and one SNP is in the 5 0 UTR. Of the coding SNPs identified, three are located in the RING, three in the B-box and two in the coiled-coil domains ( Fig. 1 ). Four of the 13 SNPs observed in this study had not been previously identified; these polymorphisms appeared at very low frequencies (<1%). All four new SNPs were identified within exon 2 of TRIM5a at bases 404 (codon 49), 505 (codon 83), 616 (codon 120) and 713 (codon 152) of the mRNA (Fig. 1 ). All sequences identified with novel SNPs can be accessed through Genbank (accession numbers FJ561487 to FJ561496).
TRIM5a SNP and exon 2 haplotype frequencies The only TRIM5a polymorphism found to be present in more than 5% of the population corresponded to the R136Q amino acid change. The three most common TRIM5a SNPs in the Pumwani sex worker cohort are those resulting in the amino acid changes R136Q (10.8%), H43Y (4.84%) and V112F (1.21%).
Single-nucleotide polymorphism distributions among different populations were compared using data provided by the Hapmap project. The three most common SNPs in the Pumwani cohort (2n ¼ 2046) were rs10838525 (R136Q), rs3740996 (H43Y) and rs11601507 (V112F We analyzed TRIM5a exon 2 haplotypes observed in the Pumwani sex worker cohort. A total of 12 different haplotypes were observed based on the variations of exon 2 sequences (Table 2 ). Only SNPs within exon 2 were included in TRIM5a haplotypes. Intron SNPs were excluded since no reliable pattern of association was observed between these SNPs and those within the exon haplotypes. Wild-type TRIM5a was the most common haplotype, presenting in 82.5% of the population. The three most common haplotypes were new2 (containing 136Q) at 10.4%, new1 (containing 43Y) at 4.4% and new4 (containing 112F) at 1.2%.
Association of TRIM5a single-nucleotide polymorphisms and haplotypes with resistance or susceptibility to HIV-1 infection TRIM5a SNPs were tested to identify associations with susceptibility or resistance to infection by HIV-1 using cross-tab analysis. Most SNPs were identified at a frequency well below 3% and did not show any significant correlations. The two SNPs identified at frequencies above 3% were SNPs rs3740996/T (H43Y) at 4.84% and rs10838525/A (R136Q) at 10.8%. The SNP rs3740996/ T (43Y), enriched in HIV-1-negative individuals in previous studies [18] , was evenly distributed between HIV-1-positive and resistant women in our cohort. Whereas studies have shown a SNP causing the amino acid change H43Y to be associated with protection against HIV-1 [18] , no correlation was observed in the Pumwani cohort ( Table 1 ). The SNP-induced amino acid change R136Q had been associated with both protection [18] and susceptibility [3] to HIV-1 in previous studies. A significant difference in the allele and phenotype frequency distributions of this SNP between HIV-1-positive and resistant women was observed in the Pumwani cohort. 136Q is strongly correlated with resistance to HIV-1 infection with an adjusted P value of 1.325E-04 (Bonferroni) and OR of 2.991 (Table 1) . These results were upheld through analysis with binary logistic regression (Table 3a) .
TRIM5a haplotypes were also analyzed for any associations with HIV-1 resistance or susceptibility ( individuals with polymorphic TRIM5a as compared to individuals with wild-type TRIM5a. Indeed, wild-type TRIM5a was more common in HIV-1-positive individuals (97.6%) than resistant individuals (92.0%), suggesting that any polymorphism may be advantageous. These associations remained significant after correcting for multiple comparisons ( Table 2 ). Sensitivity analysis, using weighted analysis yielded associations that were consistent with the results obtained using nonweighted analyses.
Association of TRIM5a single-nucleotide polymorphisms and haplotypes with reduced or increased risk of HIV-1 seroconversion The influence of TRIM5a SNPs and haplotypes on the risk of seroconversion was assessed by Kaplan-Meier survival analysis. Most SNPs and haplotypes appeared at frequencies below 3% and did not reveal any significant associations. The SNP conferring an amino acid change H43Yand exon 2 haplotype new1 were shown to have no effect on the risk of seroconversion (Fig. 2a,c) . 136Q and haplotype new2 significantly decreased the risk of seroconversion (Fig. 2b,d) . Women who are homozygous for 136Q, or haplotype new2, had not yet seroconverted at the time of this study (Fig. 2b,d) . These significant associations were also supported by Cox regression analysis (Table 3) .
To analyze the combined effect of TRIM5a polymorphisms on seroconversion, a Kaplan-Meier survival plot was generated for wild-type TRIM5a. Women who are homozygous for wild-type TRIM5a showed an increased risk of seroconversion when compared to women who are heterozygous for wild-type TRIM5a or have no wildtype TRIM5a (Fig. 2e ).
Association of TRIM5a single-nucleotide polymorphisms and haplotypes with disease progression A previous study had discovered an association between SNP H43Yand accelerated disease progression [17] . Using Kaplan-Meier survival analysis, HIV-1-positive women with various SNPs and haplotypes were compared based on the number of days with CD4 cell counts above 200 cells/ml (data not shown). No significant correlations were found between any individual SNPs or haplotypes and the rate of disease progression.
Discussion
The long-term monitoring of women in the Pumwani sex worker cohort, particularly the highly exposed persistently seronegative individuals, provides an excellent opportunity to study the natural resistance to HIV-1. Through analysis of TRIM5a exon 2 sequences of 88 HIV-1-resistant and 468 HIV-1-infected sex workers in the Pumwani sex worker cohort, we have identified a strong correlation between the SNP causing the amino acid change R136Q in the coiled-coil domain ( Table 1) and HIV-1 resistance. No significant associations were found between other TRIM5a SNPs in the region examined and HIV-1 resistance/susceptibility or disease progression.
The haplotype new2, with only one nucleotide difference from the wild-type (R136Q), also significantly associated with HIV-1 resistance ( Table 2) . Women who were HIV-1-negative at cohort enrolment and have 136Q and haplotype new2 seroconverted significantly slower than those who do not have 136Q and haplotype new2 (Fig. 2b,d) . Multivariate analysis confirmed that both 136Q and haplotype new2 were associated with resistance 1818 AIDS 2010, Vol 24 No 12 Confidence interval. Note. Haplotype new3 (GTCTCGCAG) and new 10 (GTCTCGTGG) were not observed in HIV-1þ or resistant women and thus were not included in Table 2 .
and a decreased risk of seroconversion independent from other SNPs and haplotypes in the region (Table 3b ). These findings are consistent with the results of Javanbakht et al.
[18] that R136Q is a protective polymorphism in HIV-1 infection. It is important to note that the association between 136Q and haplotype new2 with resistance against infection may be the result of linkage disequilibrium with unidentified SNP(s) in relatively close proximity to codon 136. Additional sequencing and analysis should be conducted to determine whether or not these associations are independent of other sequence variations.
Codon 136 is located within the coiled-coil domain of TRIM5a, which is required for effective recognition and binding of HIV-1 [9, 12] . It has also been suggested that the coiled-coil is needed for multimerization of TRIM5a particles, allowing effective viral binding [12, 14, 16, 22] . It is possible that variations in the amino acid sequence of the coiled-coil may alter multimerization and, in turn, the affinity of viral binding to the protein surface. Of note, most nonhuman primate TRIM5a (excluding chimpanzees) encodes a glutamine at codon 136 [18, 11] . Many of these nonhuman forms of TRIM5a have been proven to effectively restrict HIV-1 [3] [4] [5] 11] . Thus, a switch from arginine to glutamine at codon 136 in human TRIM5a could indicate a shift towards a protein that is more active against HIV-1.
Single-nucleotide polymorphism frequencies in the Pumwani cohort were similar to that of the Yoruban population from Nigeria, but quite different from those in other populations (Chinese, Japanese, Caucasian). This variation in frequency could be an important factor when considering the innate immunity of a population, particularly given the variation of the SNP encoding R136Q: 34.2% in Caucasian populations and only 4.4 and 2.3% in Chinese and Japanese populations, respect-ively. If 136Q exhibits a protective effect in all populations, the frequency of the SNP could have huge implications in the case of HIV-1 transmission.
Whereas Javanbakht et al. [18] found a connection between 43Y and protection against HIV-1 infection, we found no significant correlations between 43Yand HIV-1 resistance/susceptibility ( Table 1) or risk of seroconversion ( Fig. 2a,c) in the Pumwani sex worker cohort.
This study has not identified associations between TRIM5a SNPs or haplotypes and HIV-1 disease progression based on CD4 T-cell counts (data not shown). These results conflict with a recent study by Van Manen et al. [17] in which 43Y was found to be associated with accelerated disease progression. The same study also suggested a possible protective effect of 136Q in disease progression after the emergence of CXCR4-using HIV-1 variants, a factor we have not taken into consideration. However, on the basis of what is known of the mechanism of TRIM5a restriction, an effect on disease progression may be unexpected. TRIM5a particles able to recognize and restrict HIV-1 do so potently, inhibiting the establishment of an infection. A TRIM5a variant which is unable to prevent infection may not be efficient at recognizing or binding to HIV-1 and thus would have a limited effect on disease progression.
The ability of TRIM5a to restrict HIV-1 infection is likely dependent on the mode of viral transmission whether it is cell-free or cell-associated. There is convincing evidence that rhesus TRIM5a restriction of HIV-1 is sensitive to the mode of viral transmission; cell-free transmission is efficiently blocked by rhesus TRIM5a, whereas the extent of cell-associated restriction is much lower [23] . Cell-associated transmission has been shown to be the principle mode of infection during HIV disease progression [24] . Thus, restriction of the initial cell-free viral infection by the appropriate form of human TRIM5a may be possible, whereas cell-associated transmission during disease progression may remain largely uncontrolled.
Whereas altering levels of TRIM5a production during the course of an infection may have an effect on the degree of viral restriction, this has not yet been observed to link directly to viral load [17] . However, there is evidence for interferon-induced TRIM5a transcription [25, 26] , raising the possibility that an HIV-1 infection could trigger more effective HIV-1 restriction through large quantities of TRIM5a production.
The specific mechanism of TRIM5a-mediated restriction remains largely unknown and it is likely that many factors are involved. Further investigation is required to enhance our understanding of TRIM5a-mediated resistance to HIV-1 infection. Analysis of the full genomic sequence of TRIM5a new2 haplotype may further clarify protective TRIM5a polymorphisms.
